Attention Deficit Hyperactivity Disorder
📧 Sign up to get email alerts when something new happens for Attention Deficit Hyperactivity Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-04-17FDA Approved: DEXTROAMPHETAMINE SULFATE — Supplemental Application (Prasco Laboratories)
FDA approves a supplemental application for Dextroamphetamine Sulfate from Prasco Laboratories.
-
FDA approval · 2015-04-17FDA Approved: QUILLIVANT XR — Supplemental Application (NextWave Pharmaceuticals, Inc)
FDA approved a supplemental application for QUILLIVANT XR (methylphenidate hydrochloride) from NextWave Pharmaceuticals, Inc. This action co…
-
FDA approval · 2015-04-17FDA Approved: DEXTROAMPHETAMINE — Supplemental Application (Cranbury Pharmaceuticals, LLC)
The FDA approved a supplemental application for a dextroamphetamine product from Cranbury Pharmaceuticals, LLC.
-
FDA approval · 2015-04-17FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (NorthStar RxLLC)
The FDA approved a supplemental application from NorthStar RxLLC for a generic combination of four amphetamine salts (dextroamphetamine sacc…
-
FDA approval · 2015-04-17FDA Approved: APTENSIO XR — Original Application (Rhodes Pharmaceuticals L.P.)
The FDA approved Aptensio XR (methylphenidate hydrochloride) from Rhodes Pharmaceuticals as a new drug product for attention-deficit/hyperac…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-04-17FDA Approved: METHYLPHENIDATE HYDROCHLORIDE CD — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for methylphenidate hydrochloride CD submitted by Lannett Company, Inc., resulting in continued appr…
-
FDA approval · 2015-04-17FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (Epic Pharma, LLC)
FDA approved Epic Pharma, LLC's supplemental application for a generic combination product containing dextroamphetamine saccharate, amphetam…
-
FDA approval · 2015-04-17FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for a generic combination of dextroamphetamine and amphetamine salts (dextroamphetamine saccharate, …
-
FDA approval · 2015-04-17FDA Approved: DEXTROAMPHETAMINE SACCHARATE AND AMPHETAMINE ASPARTATE AND DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (SpecGx LLC)
FDA approves a supplemental application from SpecGx LLC for a generic product containing four amphetamine/dextroamphetamine salt forms, enab…
-
FDA approval · 2015-04-17FDA Approved: EVEKEO — Supplemental Application (Azurity Pharmaceuticals, Inc.)
The FDA approved a supplemental application for EVEKEO (amphetamine sulfate) submitted by Azurity Pharmaceuticals, Inc., under ANDA200166. T…
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Integrated Diagnosis and Treatment of Adults With Attention-deficit/Hyperactivity Disorder
This clinical trial update reports the completion of a study on integrated diagnosis and treatment of adults with attention-deficit/hyperact…
-
FDA approval · 2015-04-14FDA Approved: METHYLPHENIDATE TRANSDERMAL SYSTEM — Supplemental Application (PADAGIS US LLC)
FDA approved a supplemental application for the Methylphenidate Transdermal System from PADAGIS US LLC, signaling regulatory approval for a …
-
CLINICAL_TRIALS trial_result · 2015-04-10Clinical Trial Update: A Study of Combination Therapy in Children With ADHD [Phase 4]
A Phase 4 study evaluating a combination therapy for ADHD in children has been completed.
-
CLINICAL_TRIALS trial_result · 2015-04-06Clinical Trial Update: Computer-assisted Cognitive Rehabilitation (CACR), Placebo CACR and Psycho-stimulants in the Treatment of ADHD [Phase 3]
This clinical trial update reports the completion of a Phase 3 study evaluating computer-assisted cognitive rehabilitation, placebo CACR, an…
-
FDA approval · 2015-04-03FDA Approved: DEXTROAMPHETAMINE SULFATE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for dextroamphetamine sulfate from Actavis Pharma, Inc. under an ANDA.
-
CLINICAL_TRIALS research · 2015-04-03Clinical Trial Update: Psychological Treatment for Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) [NA]
This clinical trial update notes that the study evaluating psychological treatment for adults with Attention-deficit/hyperactivity disorder …
-
CLINICAL_TRIALS trial_result · 2015-03-31Clinical Trial Update: Dasotraline SEP360-105 Pediatric PK/PD Study [Phase 1]
This update notes the completion of a Phase 1 pediatric PK/PD study of dasotraline SEP360-105 in children with ADHD.
-
CLINICAL_TRIALS trial_result · 2015-03-23Clinical Trial Update: The Effect of Methylphenidate Versus Placebo on State Anxiety in Children With Attention Deficit Hyperactivity Disorder. [NA]
A clinical trial update assessing whether methylphenidate affects state anxiety in children with ADHD compared to placebo; the current trial…
-
FDA approval · 2015-03-20FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (SpecGx LLC)
The FDA approved a supplemental application for methylphenidate hydrochloride submitted by SpecGx LLC. This action updates the product via a…
-
CLINICAL_TRIALS trial_result · 2015-03-19Clinical Trial Update: The Correlation Between Blood omega3 and ADHD [EARLY_Phase 1]
An early-phase clinical trial update examining whether blood omega-3 levels correlate with Attention-deficit/hyperactivity disorder (ADHD). …
-
FDA approval · 2015-03-18FDA Approved: INTUNIV — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for INTUNIV (guanfacine) submitted by Takeda Pharmaceuticals America, Inc.
-
CLINICAL_TRIALS trial_result · 2015-03-18Clinical Trial Update: Disturbed Structural Connectivity of Frontostriatal and Frontoparietal Networks in Adults With ADHD
This completed clinical trial study reports disturbed structural connectivity in frontostriatal and frontoparietal networks in adults with a…
-
CLINICAL_TRIALS trial_result · 2015-03-18Clinical Trial Update: Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder [Phase 4]
A Phase 4 trial comparing Vyvanse to Concerta in adolescents with ADHD has completed and results were posted in 2015.
-
CLINICAL_TRIALS research · 2015-03-18Clinical Trial Update: Neuroendocrine Substrates, Candidate Genes and Endophenotypes in ADHD
This clinical trial update covers a study investigating neuroendocrine substrates, candidate genes, and endophenotypes in Attention Deficit …
-
CLINICAL_TRIALS trial_result · 2015-03-13Clinical Trial Update: Neuroimaging of Diet in ADHD: Phase I [NA]
Phase I trial investigating neuroimaging outcomes of dietary interventions in individuals with attention-deficit/hyperactivity disorder; the…